Rat serum osteocalcin concentration is decreased by restriction of energy intake.
We studied the effects of energy restriction on serum osteocalcin concentration and bone formation rate in rats. The experiment was designed to achieve energy restriction by reducing the carbohydrate intake while providing identical quantities of protein, fat, vitamins and minerals. Energy intakes of three groups of post-weaning male rats were restricted by 20, 40 and 60% for 4 wk. Serum calcium, phosphorus, transthyretin, triiodothyronine (T3), thyroxine (T4), 1,25-dihydroxycholecalciferol, 25-hydroxycholecalciferol and immunoreactive parathyroid hormone (iPTH) concentrations were determined. Energy restriction (20, 40 and 60%) produced a significant and gradual drop of serum osteocalcin concentrations, although the serum concentrations of its key regulators, i.e., 1,25-dihydroxycholecalciferol and iPTH, were not significantly affected. On the contrary, serum concentrations of calcium, phosphorus, transthyretin, T3 and T4 were significantly lower in the energy-restricted groups. However, our results do not support their implication in the regulation of serum osteocalcin synthesis by energy intake. Serum osteocalcin concentration was positively correlated with bone mineral apposition (r = 0.50, P < 0.05) and bone mineralization (r = 0.50, P < 0.05) rates suggesting that its decrease resulted from a reduction of bone formation, and not from abnormal mineralization, because osteoid seam thickness was not modified. Energy intake seems to be an important determinant of serum osteocalcin concentration and bone formation; however, the exact mechanism underlying this regulation remains to be determined.
Ndiaye
B
B
INSERM-GERM, Faculté de Médecine Xavier Bichat, Paris, France.
Cournot
G
G
Pélissier
M A
MA
Debray
O W
OW
Lemonnier
D
D
D000818:Animals; D001846:Bone Development / Q000502:physiology*; D002117:Calcitriol / Q000097:blood; D002118:Calcium / Q000097:blood; D004040:Dietary Carbohydrates / Q000494:pharmacology; D004435:Eating; D002149:Energy Intake / Q000502:physiology*; D005508:Food Deprivation / Q000502:physiology*; D005526:Food, Formulated; D006128:Growth / Q000187:drug effects; D008297:Male; D015675:Osteocalcin / Q000097:blood*; D010281:Parathyroid Hormone / Q000097:blood; D010758:Phosphorus / Q000097:blood; D011228:Prealbumin / Q000032:analysis; D011897:Random Allocation; D051381:Rats; D017207:Rats, Sprague-Dawley; D013974:Thyroxine / Q000097:blood; D014284:Triiodothyronine / Q000097:blood
D004040:Dietary Carbohydrates; D010281:Parathyroid Hormone; D011228:Prealbumin; D014284:Triiodothyronine; D015675:Osteocalcin; D010758:Phosphorus; D002117:Calcitriol; D013974:Thyroxine; D002118:Calcium